Heidelberg Pharma AG — Director's Dealing 2009

Nov 26, 2009

News Details

Directors’ Dealings | 26 November 2009 12:30

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Dr. Hauffe First name: Rüdiger Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: Bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Purchase Date: 26.11.2009 Price: 4.10 Currency: EUR No. of items: 1200 Total amount traded: 4920.00 Place: Außerbörslich / OTC Explanation for publication: Exercise of the subscription right Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 26.11.2009 Financial News distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 10435